See What HealthDay Can Do For You
Contact Us

Part D Has Reduced Out-of-Pocket Rx Drug Costs in Diabetes

Decrease in proportion of Part D beneficiaries who experienced coverage gap to 40.9 percent in 2011


FRIDAY, Nov. 4, 2016 (HealthDay News) -- Medicare Part D has effectively reduced the out-of-pocket cost burden of prescription drugs for beneficiaries with diabetes, according to a study published online Nov. 1 in Diabetes Care.

Yoon Jeong Choi, from Seoul National University College of Nursing in South Korea, and colleagues used Medical Expenditure Panel Survey data for 2000 to 2011 to examine out-of-pocket costs for prescription drugs for 4,664 Medicare beneficiaries (≥65 years) versus 2,938 younger, non-Medicare adults (age 50 to 60 years) with diabetes.

The researchers observed an increase in Part D enrollment of Medicare beneficiaries with diabetes from 45.7 percent in 2006 to 52.4 percent in 2011. Following Part D implementation, out-of-pocket pharmacy costs decreased by 13.5 percent for all Medicare beneficiaries with diabetes compared with 2000 to 2005; Part D beneficiaries had 5.3 percent lower costs, on average, compared to those without Part D. For Medicare beneficiaries after Part D, out-of-pocket pharmacy costs decreased by 19.4 percent compared with a younger group with diabetes. From 2006 to 2011, there was a decrease in the proportion of Part D beneficiaries with diabetes who experienced the coverage gap (60.1 to 40.9 percent).

"Although Medicare Part D has been effective in reducing the out-of-pocket cost burden of prescription drugs, approximately two out of five Part D beneficiaries with diabetes experienced the coverage gap in 2011," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.